{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:09:29Z","timestamp":1790431769472,"version":"4.1.0"},"reference-count":86,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Some osteopetrotic mutations lead to low resorption, increased numbers of osteoclasts, and increased bone formation, whereas other osteopetrotic mutations lead to low resorption, low numbers of osteoclasts, and decreased bone formation. Elaborating on these findings, we discuss the possibility that osteoclasts are the source of anabolic signals for osteoblasts. In normal healthy individuals, bone formation is coupled to bone resorption in a tight equilibrium. When this delicate balance is disturbed, the net result is pathological situations, such as osteopetrosis or osteoporosis. Human osteopetrosis, caused by mutations in proteins involved in the acidification of the resorption lacuna (ClC-7 or the a3-V-ATPase), is characterized by decreased resorption in face of normal or even increased bone formation. Mouse mutations leading to ablation of osteoclasts (e.g., loss of macrophage-colony stimulating factor [M-CSF] or c-fos) lead to secondary negative effects on bone formation, in contrast to mutations where bone resorption is abrogated with sustained osteoclast numbers, such as the c-src mice. These data indicate a central role for osteoclasts, and not necessarily their resorptive activity, in the control of bone formation. In this review, we consider the balance between bone resorption and bone formation, reviewing novel data that have shown that this principle is more complex than originally thought. We highlight the distinct possibility that osteoclast function can be divided into two more or less separate functions, namely bone resorption and stimulation of bone formation. Finally, we describe the likely possibility that bone resorption can be attenuated pharmacologically without the undesirable reduction in bone formation.<\/jats:p>","DOI":"10.1359\/jbmr.070109","type":"journal-article","created":{"date-parts":[[2007,1,16]],"date-time":"2007-01-16T19:40:03Z","timestamp":1168976403000},"page":"487-494","source":"Crossref","is-referenced-by-count":206,"title":["Are Nonresorbing Osteoclasts Sources of Bone Anabolic Activity?"],"prefix":"10.1093","volume":"22","author":[{"given":"Morten A","family":"Karsdal","sequence":"first","affiliation":[{"name":"Nordic Bioscience A\/S, Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J","family":"Martin","sequence":"additional","affiliation":[{"name":"St Vincent's Institute of Medical Research, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Bollerslev","sequence":"additional","affiliation":[{"name":"Section of Medical Endocrinology, University Hospital of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Christiansen","sequence":"additional","affiliation":[{"name":"Center for Clinical and Basic Research, CCBR, Ballerup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Henriksen","sequence":"additional","affiliation":[{"name":"Nordic Bioscience A\/S, Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,12,4]]},"reference":[{"key":"2024020319312851500_bib1","volume-title":"Anatomy and Biology of Bone Matrix and Cellular Elements, Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","author":"Baron","year":"2003"},{"key":"2024020319312851500_bib2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/206489a0","article-title":"Suggested sequential mode of control of changes in cell behaviour in adult bone remodelling","volume":"206","author":"Hattner","year":"1965","journal-title":"Nature"},{"key":"2024020319312851500_bib3","first-page":"437","article-title":"Resorption precedes formative activity","volume":"15","author":"Takahashi","year":"1964","journal-title":"Surg Forum"},{"key":"2024020319312851500_bib4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00003086-197101000-00035","article-title":"Tetracycline-based study of bone dynamics in pycnodysostosis","volume":"74","author":"Sarnsethsiri","year":"1971","journal-title":"Clin Orthop"},{"key":"2024020319312851500_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0221-8747(82)90002-9","article-title":"The coupling of bone formation to bone resorption: A critical analysis of the concept and of its relevance to the pathogenesis of osteoporosis","volume":"4","author":"Parfitt","year":"1982","journal-title":"Metab Bone Dis Relat Res"},{"issue":"Suppl 1","key":"2024020319312851500_bib6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF01621884","article-title":"Hormones in the coupling of bone resorption and formation","volume":"3","author":"Martin","year":"1993","journal-title":"Osteoporos Int"},{"key":"2024020319312851500_bib7","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1210\/en.2003-0717","article-title":"Osteoprotegerin regulates bone formation through a coupling mechanism with bone resorption","volume":"144","author":"Nakamura","year":"2003","journal-title":"Endocrinology"},{"key":"2024020319312851500_bib8","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nrg1122","article-title":"Genetic regulation of osteoclast development and function","volume":"4","author":"Teitelbaum","year":"2003","journal-title":"Nat Rev Genet"},{"key":"2024020319312851500_bib9","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/nrd916","article-title":"Discoveries, drugs and skeletal disorders","volume":"1","author":"Goltzman","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"2024020319312851500_bib10","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1056\/NEJMra040952","article-title":"Osteopetrosis","volume":"351","author":"Tolar","year":"2004","journal-title":"N Engl J Med"},{"key":"2024020319312851500_bib11","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/jbmr.5650060602","article-title":"Mechanical loading, estrogen deficiency, and the coupling of bone formation to bone resorption","volume":"6","author":"Rodan","year":"1991","journal-title":"J Bone Miner Res"},{"key":"2024020319312851500_bib12","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1359\/jbmr.2000.15.8.1526","article-title":"Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: The OFELY study","volume":"15","author":"Garnero","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2024020319312851500_bib13","first-page":"2363","article-title":"Monitoring of alendronate treatment and prediction of effect on bone mass by biochemical markers in the early postmenopausal intervention cohort study","volume":"84","author":"Ravn","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020319312851500_bib14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S8756-3282(98)00183-5","article-title":"Biochemical markers can predict the response in bone mass during alendronate treatment in early postmenopausal women. Alendronate Osteoporosis Prevention Study Group","volume":"24","author":"Ravn","year":"1999","journal-title":"Bone"},{"key":"2024020319312851500_bib15","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S8756-3282(03)00168-6","article-title":"Biochemical markers for prediction of 4-year response in bone mass during bisphosphonate treatment for prevention of postmenopausal osteoporosis","volume":"33","author":"Ravn","year":"2003","journal-title":"Bone"},{"key":"2024020319312851500_bib16","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S8756-3282(02)00707-X","article-title":"Effects of biomechanical stress on bones in animals","volume":"30","author":"Burr","year":"2002","journal-title":"Bone"},{"key":"2024020319312851500_bib17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S8756-3282(01)00619-6","article-title":"Targeted and nontargeted remodeling","volume":"30","author":"Burr","year":"2002","journal-title":"Bone"},{"key":"2024020319312851500_bib18","volume-title":"Biomechanics of Bone","author":"Burr","year":"2003"},{"issue":"Suppl","key":"2024020319312851500_bib19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/BF03026323","article-title":"Microdamage accumulation in the monkey vertebra does not occur when bone turnover is suppressed by 50% or less with estrogen or raloxifene","volume":"23","author":"Li","year":"2005","journal-title":"J Bone Miner Metab"},{"issue":"Suppl","key":"2024020319312851500_bib20","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/BF03026321","article-title":"The effects of suppressed bone remodeling by bisphosphonates on microdamage accumulation and degree of mineralization in the cortical bone of dog rib","volume":"23","author":"Mashiba","year":"2005","journal-title":"J Bone Miner Metab"},{"key":"2024020319312851500_bib21","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s002230010036","article-title":"Bisphosphonate treatment suppresses not only stochastic remodeling but also the targeted repair of microdamage","volume":"69","author":"Li","year":"2001","journal-title":"Calcif Tissue Int"},{"key":"2024020319312851500_bib22","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S8756-3282(01)00414-8","article-title":"Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles","volume":"28","author":"Mashiba","year":"2001","journal-title":"Bone"},{"key":"2024020319312851500_bib23","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1359\/jbmr.2000.15.4.613","article-title":"Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib","volume":"15","author":"Mashiba","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2024020319312851500_bib24","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.molmed.2004.12.004","article-title":"Osteoclast-derived activity in the coupling of bone formation to resorption","volume":"11","author":"Martin","year":"2005","journal-title":"Trends Mol Med"},{"key":"2024020319312851500_bib25","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1210\/endo-97-2-283","article-title":"Increases in number and size of osteoclasts in response to calcium or phosphorus deficiency in the rat","volume":"97","author":"Thompson","year":"1975","journal-title":"Endocrinology"},{"key":"2024020319312851500_bib26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1749-6632.1990.tb16102.x","article-title":"Role of TGF beta in bone remodeling","volume":"593","author":"Mundy","year":"1990","journal-title":"Ann N Y Acad Sci"},{"key":"2024020319312851500_bib27","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.2106\/00004623-199173090-00022","article-title":"Transforming growth factor-beta and remodeling of bone","volume":"73","author":"Centrella","year":"1991","journal-title":"J Bone Joint Surg Am"},{"key":"2024020319312851500_bib28","doi-asserted-by":"crossref","first-page":"93S","DOI":"10.1016\/8756-3282(95)00186-H","article-title":"The insulin-like growth factor system and the coupling of formation to resorption","volume":"17","author":"Hayden","year":"1995","journal-title":"Bone"},{"issue":"Suppl 2","key":"2024020319312851500_bib29","doi-asserted-by":"crossref","first-page":"S565","DOI":"10.1002\/jbmr.5650081326","article-title":"Growth factors to stimulate bone formation","volume":"8","author":"Baylink","year":"1993","journal-title":"J Bone Miner Res"},{"key":"2024020319312851500_bib30","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1073\/pnas.78.5.3204","article-title":"Parathyroid hormone stimulates bone formation and resorption in organ culture: Evidence for a coupling mechanism","volume":"78","author":"Howard","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024020319312851500_bib31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0002-9440(10)63798-4","article-title":"Genotype-phenotype relationship in human ATP6i-dependent autosomal recessive osteopetrosis","volume":"162","author":"Taranta","year":"2003","journal-title":"Am J Pathol"},{"key":"2024020319312851500_bib32","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S0002-9440(10)63712-1","article-title":"Characterization of osteoclasts from patients harboring a G215R mutation in ClC-7 causing autosomal dominant osteopetrosis type II (ADOII)","volume":"164","author":"Henriksen","year":"2004","journal-title":"Am J Pathol"},{"key":"2024020319312851500_bib33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/8756-3282(89)90142-7","article-title":"Structural and histomorphometric studies of iliac crest trabecular and cortical bone in autosomal dominant osteopetrosis: A study of two radiological types","volume":"10","author":"Bollerslev","year":"1989","journal-title":"Bone"},{"key":"2024020319312851500_bib34","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1373\/clinchem.2003.029355","article-title":"Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers-Schonberg disease (type II autosomal dominant osteopetrosis)","volume":"50","author":"Alatalo","year":"2004","journal-title":"Clin Chem"},{"key":"2024020319312851500_bib35","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/jmg.2005.036673","article-title":"Clinical, genetic and cellular analysis of forty-nine osteopetrotic patients: Implications for diagnosis and treatment","volume":"43","author":"Del Fattore","year":"2005","journal-title":"J Med Genet"},{"key":"2024020319312851500_bib36","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/8756-3282(93)90316-3","article-title":"Ultrastructural investigations of bone resorptive cells in two types of autosomal dominant osteopetrosis","volume":"14","author":"Bollerslev","year":"1993","journal-title":"Bone"},{"key":"2024020319312851500_bib37","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0002-9440(10)62269-9","article-title":"Acidification of the osteoclastic resorption compartment provides insight into the coupling of bone formation to bone resorption","volume":"166","author":"Karsdal","year":"2005","journal-title":"Am J Pathol"},{"key":"2024020319312851500_bib38","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1210\/jc.2003-031055","article-title":"Decreased bone turnover and deterioration of bone structure in two cases of pycnodysostosis","volume":"89","author":"Fratzl-Zelman","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020319312851500_bib39","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1359\/jbmr.1999.14.11.1902","article-title":"Determination of bone markers in pycnodysostosis: Effects of cathepsin K deficiency on bone matrix degradation","volume":"14","author":"Nishi","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2024020319312851500_bib40","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1083\/jcb.151.2.311","article-title":"Decreased c-Src expression enhances osteoblast differentiation and bone formation","volume":"151","author":"Marzia","year":"2000","journal-title":"J Cell Biol"},{"key":"2024020319312851500_bib41","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0092-8674(01)00206-9","article-title":"Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man","volume":"104","author":"Kornak","year":"2001","journal-title":"Cell"},{"key":"2024020319312851500_bib42","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0092-8674(91)90499-O","article-title":"Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice","volume":"64","author":"Soriano","year":"1991","journal-title":"Cell"},{"key":"2024020319312851500_bib43","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1083\/jcb.119.4.1003","article-title":"Osteoclasts express high levels of pp60c-src in association with intracellular membranes","volume":"119","author":"Horne","year":"1992","journal-title":"J Cell Biol"},{"key":"2024020319312851500_bib44","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/70563","article-title":"Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification","volume":"23","author":"Li","year":"1999","journal-title":"Nat Genet"},{"key":"2024020319312851500_bib45","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1172\/JCI6145","article-title":"A selective inhibitor of the osteoclastic V-H(+)-ATPase prevents bone loss in both thyroparathyroidectomized and ovariectomized rats","volume":"106","author":"Visentin","year":"2000","journal-title":"J Clin Invest"},{"key":"2024020319312851500_bib46","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00001665-200305000-00007","article-title":"Proton pump inhibitors control osteoclastic resorption of calcium phosphate implants and stimulate increased local reparative bone growth","volume":"14","author":"Rzeszutek","year":"2003","journal-title":"J Craniofac Surg"},{"key":"2024020319312851500_bib47","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1359\/JBMR.040302","article-title":"The chloride channel inhibitor n53736 prevents bone resorption in ovariectomized rats without changing bone formation","volume":"19","author":"Schaller","year":"2004","journal-title":"J Bone Miner Res"},{"key":"2024020319312851500_bib48","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1359\/JBMR.040514","article-title":"Osteoclast deficiency results in disorganized matrix, reduced mineralization, and abnormal osteoblast behavior in developing bone","volume":"19","author":"Dai","year":"2004","journal-title":"J Bone Miner Res"},{"key":"2024020319312851500_bib49","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.micron.2005.06.008","article-title":"Reduced osteoblastic population and defective mineralization in osteopetrotic (op\/op) mice","volume":"36","author":"Sakagami","year":"2005","journal-title":"Micron"},{"key":"2024020319312851500_bib50","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMoa044459","article-title":"Denosumab in postmenopausal women with low bone mineral density","volume":"354","author":"McClung","year":"2006","journal-title":"N Engl J Med"},{"key":"2024020319312851500_bib51","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S0006-291X(02)00598-3","article-title":"Mutation of macrophage colony stimulating factor (Csf1) causes osteopetrosis in the tl rat","volume":"294","author":"Dobbins","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"2024020319312851500_bib52","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1210\/endo-126-2-955","article-title":"Osteopetrosis in the rat: Coexistence of reductions in osteocalcin and bone resorption","volume":"126","author":"Lian","year":"1990","journal-title":"Endocrinology"},{"key":"2024020319312851500_bib53","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1359\/jbmr.2000.15.10.1905","article-title":"Mineral density and bone strength are dissociated in long bones of rat osteopetrotic mutations","volume":"15","author":"Tuukkanen","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2024020319312851500_bib54","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1210\/en.2002-220221","article-title":"Anabolic actions of parathyroid hormone during bone growth are dependent on c-fos","volume":"143","author":"Demiralp","year":"2002","journal-title":"Endocrinology"},{"key":"2024020319312851500_bib55","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11914-005-0023-9","article-title":"Does early PTH treatment compromise bone strength? The balance between remodeling, porosity, bone mineral, and bone size","volume":"3","author":"Burr","year":"2005","journal-title":"Curr Osteoporos Rep"},{"key":"2024020319312851500_bib56","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1210\/en.2005-0333","article-title":"Cells of the osteoclast lineage as mediators of the anabolic actions of parathyroid hormone in bone","volume":"146","author":"Koh","year":"2005","journal-title":"Endocrinology"},{"key":"2024020319312851500_bib57","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1172\/JCI28084","article-title":"Glucocorticoids suppress bone formation via the osteoclast","volume":"116","author":"Kim","year":"2006","journal-title":"J Clin Invest"},{"key":"2024020319312851500_bib58","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1359\/jbmr.2002.17.1.77","article-title":"The bone lining cell: Its role in cleaning Howship's lacunae and initiating bone formation","volume":"17","author":"Everts","year":"2002","journal-title":"J Bone Miner Res"},{"key":"2024020319312851500_bib59","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF00187292","article-title":"Simulation of bone resorption-repair coupling in vitro","volume":"190","author":"Jones","year":"1994","journal-title":"Anat Embryol (Berl)"},{"key":"2024020319312851500_bib60","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1902\/jop.2000.71.4.586","article-title":"Osteoblast proliferation and differentiation on dentin slices are modulated by pretreatment of the surface with tetracycline or osteoclasts","volume":"71","author":"Schwartz","year":"2000","journal-title":"J Periodontol"},{"key":"2024020319312851500_bib61","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1074\/jbc.M208292200","article-title":"A phage display technique identifies a novel regulator of cell differentiation","volume":"278","author":"Sheu","year":"2003","journal-title":"J Biol Chem"},{"key":"2024020319312851500_bib62","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1359\/jbmr.2002.17.5.915","article-title":"Use of a phage display technique to identify potential osteoblast binding sites within osteoclast lacunae","volume":"17","author":"Sheu","year":"2002","journal-title":"J Bone Miner Res"},{"key":"2024020319312851500_bib63","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1359\/jbmr.1999.14.10.1654","article-title":"Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization","volume":"14","author":"Gowen","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2024020319312851500_bib64","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S8756-3282(02)00675-0","article-title":"A potent small molecule, nonpeptide inhibitor of cathepsin K (SB 331750) prevents bone matrix resorption in the ovariectomized rat","volume":"30","author":"Lark","year":"2002","journal-title":"Bone"},{"issue":"S1","key":"2024020319312851500_bib65","first-page":"F232","article-title":"Treatment of young male monkeys for 12 months with a highly potent inhibitor of cathepsin K inhibits bone resorption and increases bone mineral density and strength","volume":"20","author":"Kumar","year":"2005","journal-title":"J Bone Miner Res"},{"issue":"Suppl 1","key":"2024020319312851500_bib66","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1080\/03008200390181717","article-title":"Mechanisms by which extracellular matrix components induce osteoblast apoptosis","volume":"44","author":"Adams","year":"2003","journal-title":"Connect Tissue Res"},{"key":"2024020319312851500_bib67","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1359\/jbmr.060313","article-title":"Mice lacking cathepsin K maintain bone remodeling but develop bone fragility despite high bone mass","volume":"21","author":"Li","year":"2006","journal-title":"J Bone Miner Res"},{"key":"2024020319312851500_bib68","doi-asserted-by":"crossref","first-page":"93S","DOI":"10.1016\/8756-3282(95)00186-H","article-title":"The insulin-like growth factor system and the coupling of formation to resorption","volume":"17","author":"Hayden","year":"1995","journal-title":"Bone"},{"issue":"S2","key":"2024020319312851500_bib69","doi-asserted-by":"crossref","first-page":"S565","DOI":"10.1002\/jbmr.5650081326","article-title":"Growth factors to stimulate bone formation","volume":"8","author":"Baylink","year":"1993","journal-title":"J Bone Miner Res"},{"key":"2024020319312851500_bib70","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.286.5446.1946","article-title":"Stimulation of bone formation in vitro and in rodents by statins","volume":"286","author":"Mundy","year":"1999","journal-title":"Science"},{"key":"2024020319312851500_bib71","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1172\/JCI19872","article-title":"Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways","volume":"113","author":"Sims","year":"2004","journal-title":"J Clin Invest"},{"key":"2024020319312851500_bib72","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1172\/JCI0215687","article-title":"Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency","volume":"110","author":"Weitzmann","year":"2002","journal-title":"J Clin Invest"},{"key":"2024020319312851500_bib73","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa013444","article-title":"High bone density due to a mutation in LDL-receptor-related protein 5","volume":"346","author":"Boyden","year":"2002","journal-title":"N Engl J Med"},{"key":"2024020319312851500_bib74","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/8756-3282(94)90282-8","article-title":"Regional variation of insulin-like growth factor-I gene expression in mature rat bone and cartilage","volume":"15","author":"Lazowski","year":"1994","journal-title":"Bone"},{"key":"2024020319312851500_bib75","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1210\/endo.137.2.8593810","article-title":"Osteoclasts and transforming growth factor-beta: Estrogen-mediated isoform-specific regulation of production","volume":"137","author":"Robinson","year":"1996","journal-title":"Endocrinology"},{"key":"2024020319312851500_bib76","doi-asserted-by":"crossref","first-page":"44005","DOI":"10.1074\/jbc.M208265200","article-title":"Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization","volume":"277","author":"Zhang","year":"2002","journal-title":"J Biol Chem"},{"key":"2024020319312851500_bib77","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1359\/jbmr.2002.17.9.1570","article-title":"Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone","volume":"17","author":"Bikle","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"S1","key":"2024020319312851500_bib78","first-page":"M198","article-title":"Osteoclasts secrete non-bone derived signals that induce bone nodule formation","volume":"21","author":"Henriksen","year":"2006","journal-title":"J Bone Miner Res"},{"issue":"S1","key":"2024020319312851500_bib79","first-page":"SA418","article-title":"Osteoclast number but not activity may be the determinant factor for sustained osteoclast effect on bone formation","volume":"21","author":"Henriksen","year":"2006","journal-title":"J Bone Miner Res"},{"key":"2024020319312851500_bib80","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cmet.2006.05.012","article-title":"Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis","volume":"4","author":"Zhao","year":"2006","journal-title":"Cell Metab"},{"key":"2024020319312851500_bib81","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cell.2006.07.015","article-title":"Boning up on ephrin signaling","volume":"126","author":"Mundy","year":"2006","journal-title":"Cell"},{"key":"2024020319312851500_bib82","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00198-004-1634-1","article-title":"Reference database of biochemical markers of bone turnover for the Japanese female population. Japanese Population-based Osteoporosis (JPOS) Study","volume":"15","author":"Iki","year":"2004","journal-title":"Osteoporos Int"},{"key":"2024020319312851500_bib83","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1359\/JBMR.040305","article-title":"A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women","volume":"19","author":"Bekker","year":"2004","journal-title":"J Bone Miner Res"},{"key":"2024020319312851500_bib84","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1359\/jbmr.1998.13.9.1431","article-title":"Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: A randomized clinical trial","volume":"13","author":"Greenspan","year":"1998","journal-title":"J Bone Miner Res"},{"key":"2024020319312851500_bib85","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa031975","article-title":"The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis","volume":"349","author":"Black","year":"2003","journal-title":"N Engl J Med"},{"key":"2024020319312851500_bib86","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa035725","article-title":"The effects of parathyroid hormone, alendronate, or both in men with osteoporosis","volume":"349","author":"Finkelstein","year":"2003","journal-title":"N Engl J Med"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1359%2Fjbmr.070109","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/22\/4\/487\/56552235\/5650220401.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/22\/4\/487\/56552235\/5650220401.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T10:48:24Z","timestamp":1710326904000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/22\/4\/487-494\/7597312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,1]]},"references-count":86,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2009,12,4]]},"published-print":{"date-parts":[[2007,4,1]]}},"URL":"https:\/\/doi.org\/10.1359\/jbmr.070109","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2007,4,1]]},"published":{"date-parts":[[2007,4,1]]}}}